Comparative proteomics of small cell lung carcinoma

Cancer Biomarkers

Volumn 2, Issue 6, 2006, Pages 219-234

  Ziv, Tamar ^a   Barnea, Eilon ^a   Segal, Hava ^a   Sharon, Rivka ^a   Beer, Ilan ^b   Admon, Arie ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b IBM HAIFA RESEARCH LAB   (Israel)

Author keywords

cancer proteins; mass spectrometry; Proteomics; small cell lung carcinoma; two dimensional gel electrophoresis; two dimensional liquid chromatography

Indexed keywords

TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; COMPARATIVE STUDY; HUMAN; LUNG TUMOR; METABOLISM; PROTEOMICS; SMALL CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA, SMALL CELL; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 34248586022     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2006-2601     Document Type: Article

References (36)

1. C.S. Bangur, A. Switzer, L. Fan, M.J. Marton, M.R. Meyer and T. Wang, Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis, Oncogene 21 (2002), 3814-3825.
2. I. Beer, E. Barnea, T. Ziv and A. Admon, Improving largescale proteomics by clustering of mass spectrometry data, Proteomics 4 (2004), 950-960.
3. P.A. Bunn, Jr., F.A. Shepherd, A. Sandler, T. Le Chevalier, C.P. Belani, P.A. Kosmidis, G.V. Scagliotti and G. Giaccone, Ongoing and future trials of biologic therapies in lung cancer, Lung Cancer 41 (2003), S175-S186.
4. D.N. Carney, A.F. Gazdar, G. Bepler, J.G. Guccion, P.J. Marangos, T.W. Moody, M.H. Zweig and J.D. Minna, Establishment and identification of small cell lung cancer cell lines having classic and variant features, Cancer Res 45 (1985), 2913-2923.
5. J.E. Celis and P. Gromov, Proteomics in translational cancer research: toward an integrated approach, Cancer Cell 3 (2003), 9-15.
6. Y.J. Chua, C. Steer and D. Yip, Recent advances in management of small-cell lung cancer, Cancer Treat Rev 30 (2004), 521-543.
7. J.M. Coulson, M. Ocejo-Garcia and P.J.Woll, Neuroendocrine phenotype of small cell lung cancer, Methods Mol Med 74 (2003), 61-73.
8. C.A. Granville and P.A. Dennis, An overview of lung cancer genomics and proteomics, Am J Respir Cell Mol Biol 32 (2005), 169-176.
9. S. Hanash, Disease proteomics, Nature 422 (2003), 226-232.
10. L. He, J. Liu, I. Collins, S. Sanford, B. O'Connell, C.J. Benham and D. Levens, Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression, Embo J 19 (2000), 1034-1044.
11. L. He, A. Weber and D. Levens, Nuclear targeting determinants of the far upstream element binding protein, a cmyctranscription factor, Nucleic Acids Res 28 (2000), 4558-4565.
12. G.M. Hellmann, W.R. Fields and D.J. Doolittle, Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells, Toxicol Sci 61 (2001), 154-163.
13. B.E. Johnson, J.F. Brennan, D.C. Ihde and A.F. Gazdar, myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer, J Natl Cancer Inst Monogr (1992), 39-43.
14. S. Julka and F. Regnier, Quantification in proteomics through stable isotope coding: a review, J Proteome Res 3 (2004), 350-363.
15. R. Komaki, Combined treatment for limited small cell lung cancer, Semin Oncol 30 (2003), 56-70.
16. M.K. Koutsami, I. Doussis-Anagnostopoulou, A.G. Papavassiliou and V.G. Gorgoulis, Genetic and molecular coordinates of neuroendocrine lung tumors, with emphasis on small-cell lung carcinomas, Mol Med 8 (2002), 419-436.
17. L.M. Krug, Vaccine therapy for small cell lung cancer, Semin Oncol 31 (2004), 112-116.
18. L.M. Krug, G. Ragupathi, K.K. Ng, C. Hood, H.J. Jennings, Z. Guo, M.G. Kris,V. Miller, B. Pizzo, L. Tyson,V. Baez and P.O. Livingston, Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin, ClinCancer Res 10 (2004), 916-923.
19. A.J. Link, J. Eng, D.M. Schieltz, E. Carmack, G.J. Mize, D.R. Morris, B.M. Garvik and J.R. Yates, 3rd, Direct analysis of protein complexes using mass spectrometry, Nat Biotechnol 17 (1999), 676-682.
20. J. Liu, L. He, I. Collins, H. Ge, D. Libutti, J. Li, J.M. Egly and D. Levens, The FBP interacting repressor targets TFIIH to inhibit activated transcription, Mol Cell 5 (2000), 331-341.
21. P.C. Ma, L. Blaszkowsky, A. Bharti, A. Ladanyi, S.K. Kraeft, A. Bruno, A.T. Skarin, L.B. Chen and R. Salgia, Circulating tumor cells and serum tumor biomarkers in small cell lung cancer, Anticancer Res 23 (2003), 49-62.
22. L. Mao, Recent advances in the molecular diagnosis of lung cancer, Oncogene 21 (2002), 6960-6969.
23. R. Meuwissen, S.C. Linn, R.I. Linnoila, J. Zevenhoven, W.J. Mooi and A. Berns, Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model, Cancer Cell 4 (2003), 181-189.
24. N. Murray, R. Salgia and F.V. Fossella, Targeted molecules in small cell lung cancer, Semin Oncol 31 (2004), 106-111.
25. M.A. Nikiforov, S. Chandriani, B. O'Connell, O. Petrenko, I. Kotenko, A. Beavis, J.M. Sedivy and M.D. Cole, A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism, Mol Cell Biol 22 (2002), 5793-5800.
26. J.A. Nilsson and J.L. Cleveland, Myc pathways provoking cell suicide and cancer, Oncogene 22 (2003), 9007-9021.
27. J.M. Oh, F. Brichory, E. Puravs, R. Kuick, C. Wood, J.M. Rouillard, J. Tra, S. Kardia, D. Beer and S. Hanash, Adatabase of protein expression in lung cancer, Proteomics 1 (2001), 1303-1319.
28. J. Patel, L. Krug, C. Azzoli, J. Gomez, M. Kris and V. Miller, Targeting lethal minimal residual disease in small cell lung cancer, Seminars in Oncology 30 (2003), 79-85.
29. N. Pedersen, S. Mortensen, S.B. Sorensen, M.W. Pedersen, K. Rieneck, L.F. Bovin and H.S. Poulsen, Transcriptional gene expression profiling of small cell lung cancer cells, Cancer Res 63 (2003), 1943-1953.
30. E. Petricoin, J. Wulfkuhle, V. Espina and L.A. Liotta, Clinical proteomics: revolutionizing disease detection and patient tailoring therapy, J Proteome Res 3 (2004), 209-217.
31. A. Rossi, P. Maione, G. Colantuoni, C. Guerriero and C. Gridelli, The role of new targeted therapies in small-cell lung cancer, Crit Rev Oncol Hematol 51 (2004), 45-53.
32. T.K. Taneja and S. Sharma, Markers of small cell lung cancer, World J Surg Oncol 2 (2004), 10.
33. H. Uramoto, H. Izumi, T. Ise, M. Tada, T. Uchiumi, M. Kuwano, K. Yasumoto, K. Funa and K. Kohno, p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression, J Biol Chem 277 (2002), 31694-31702.
34. C. Virtanen, Y. Ishikawa, D. Honjoh, M. Kimura, M. Shimane, T. Miyoshi, H. Nomura and M.H. Jones, Integrated classification of lung tumors and cell lines by expression profiling, Proc Natl Acad Sci USA 99 (2002), 12357-12362.
35. D.R. Wonsey, K.I. Zeller and C.V. Dang, The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation, PNAS 99 (2002), 6649-6654.
36. L. Zhang, R.E. Cilley and M.R. Chinoy, Suppression subtractive hybridization to identify gene expressions in variant and classic small cell lung cancer celllines, J Surg Res 93 (2000), 108-119.